Phillip Coffin, M.D., M.I.A., is the Director of Substance Use Research in the Center for Public Health Research at the San Francisco Department of Public Health. He is a board certified internal medicine and infectious diseases clinician; specific foci of Dr. Coffin’s training include HIV management, buprenorphine maintenance, addiction ... WebbPhillip Coffin, M.D. (510) 869-6883 Alta Bates Summit Medical Center Summit Campus 350 Hawthorne Avenue Suite 2346 Oakland , CA 94609 Hospitalist Affiliations Hospital Affiliations Alta Bates Summit Medical Center - Alta Bates Campus Alta Bates Summit …
Dr. Phillip Coffin M.D., Hospitalist in Oakland, CA Sutter Health
WebbDr. Phillip Coffin is a board-certified and practicing internist, infectious disease specialist, and addiction medicine specialist. He has attended or trained at Brown University, Columbia University, the University of California San Francisco, and the University of … Webb21 mars 2014 · Phillip Coffin, MD, MIA, San Francisco Department of Public Health Study Details Tabular View No Results Posted Disclaimer How to Read a Study Record Study Description Go to Brief Summary: REBOOT is a pilot randomized trial of a repeated-dose brief intervention to reduce overdose and risk behaviors among naloxone recipients … dialysate ph should be
Our team Center for Innovation in Academic Detailing on Opioids
WebbDr. Phillip Coffin, MD, MIA, FACP, FIDSA is the Director of Substance Use Research at the San Francisco Department of Public Health. Dr. Jonathan Davis, MD, MPHS, is the Director of the San Francisco Health Network, Heart Failure Program. Resource Provided: To claim CE Date added: March 14, 2024 Add to myECHO Post navigation Webb12 feb. 2024 · Phillip O. Coffin, M.D., and Antje M. Barreveld, M.D. Article Figures/Media Metrics Related Articles; Patients who have taken opioids for years for ... Webb12 feb. 2024 · Phillip Coffin, MD, MIA, Director, Substance Use Research Unit, San Francisco Department of Public Health: ClinicalTrials.gov Identifier: NCT03838510 Other Study ID Numbers: 5R01DA045690-02 ( U.S. NIH Grant/Contract ) First Posted: February 12, 2024 Key Record Dates: Last Update Posted: August 16, 2024 Last Verified: cipher lab rs35